Chronic viral hepatitis and its association with liver cancer

References

Abbas, Z., Abbas, M., Abbas, S., and Shazi, L. (2015). Hepatitis D and hepatocellular carcinoma. World J. Hepatol. 7, 777–786.10.4254/wjh.v7.i5.777Search in Google Scholar PubMed PubMed Central

Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Borresen-Dale, A.L., et al. (2013). Signatures of mutational processes in human cancer. Nature 500, 415–421.10.1038/nature12477Search in Google Scholar PubMed PubMed Central

Ariumi, Y., Kuroki, M., Abe, K., Dansako, H., Ikeda, M., Wakita, T., and Kato, N. (2007). DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 81, 13922–13926.10.1128/JVI.01517-07Search in Google Scholar PubMed PubMed Central

Bai, S., Nasser, M.W., Wang, B., Hsu, S.H., Datta, J., Kutay, H., Yadav, A., Nuovo, G., Kumar, P., and Ghoshal, K. (2009). MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J. Biol. Chem. 284, 32015–32027.10.1074/jbc.M109.016774Search in Google Scholar PubMed PubMed Central

Barash, H.E.R.G., Edrei, Y., Ella, E., Israel, A., Cohen, I., Corchia, N., Ben-Moshe, T., Pappo, O., Pikarsky, E., Goldenberg, D., et al. (2010). Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc. Natl. Acad. Sci. USA 107, 2207–2212.10.1073/pnas.0908867107Search in Google Scholar PubMed PubMed Central

Bartenschlager, R., Penin, F., Lohmann, V., and Andre, P. (2011). Assembly of infectious hepatitis C virus particles. Trends. Microbiol. 19, 95–103.10.1016/j.tim.2010.11.005Search in Google Scholar PubMed

Bartosch, B., Verney, G., Dreux, M., Donot, P., Morice, Y., Penin, F., Pawlotsky, J.M., Lavillette, D., and Cosset, F.L. (2005). An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J. Virol. 79, 8217–8229.10.1128/JVI.79.13.8217-8229.2005Search in Google Scholar PubMed PubMed Central

Bayliss, J., Lim, L., Thompson, A.J., Desmond, P., Angus, P., Locarnini, S., and Revill, P.A. (2013). Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma. J. Hepatol. 59, 1022–1028.10.1016/j.jhep.2013.06.018Search in Google Scholar PubMed

Beloribi-Djefaflia, S., Vasseur, S., and Guillaumond, F. (2016). Lipid metabolic reprogramming in cancer cells. Oncogenesis 5, e189.10.1038/oncsis.2015.49Search in Google Scholar PubMed PubMed Central

Benali-Furet, N.L., Chami, M., Houel, L., De Giorgi, F., Vernejoul, F., Lagorce, D., Buscail, L., Bartenschlager, R., Ichas, F., Rizzuto, R., et al. (2005). Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene 24, 4921–4933.10.1038/sj.onc.1208673Search in Google Scholar PubMed

Betz-Stablein, B.D., Topfer, A., Littlejohn, M., Yuen, L., Colledge, D., Sozzi, V., Angus, P., Thompson, A., Revill, P., Beerenwinkel, N., et al. (2016). Single-Molecule sequencing reveals complex genome variation of hepatitis B virus during 15 years of chronic infection following liver transplantation. J. Virol. 90, 7171–7183.10.1128/JVI.00243-16Search in Google Scholar PubMed PubMed Central

Bility, M.T., Cheng, L., Zhang, Z., Luan, Y., Li, F., Chi, L., Zhang, L., Tu, Z., Gao, Y., Fu, Y., et al. (2014). Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog. 10, e1004032.10.1371/journal.ppat.1004032Search in Google Scholar PubMed PubMed Central

Bill, C.A. and Summers, J. (2004). Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc. Natl. Acad. Sci. USA 101, 11135–11140.10.1073/pnas.0403925101Search in Google Scholar PubMed PubMed Central

Billerbeck, E., Mommersteeg, M.C., Shlomai, A., Xiao, J.W., Andrus, L., Bhatta, A., Vercauteren, K., Michailidis, E., Dorner, M., Krishnan, A., et al. (2016). Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. J. Hepatol. 65, 334–343.10.1016/j.jhep.2016.04.022Search in Google Scholar PubMed PubMed Central

Bode, J., Stengert-Iber, M., Kay, V., Schlake, T., and Dietz-Pfeilstetter, A. (1996). Scaffold/matrix-attached regions: topological switches with multiple regulatory functions. Crit. Rev. Eukaryot. Gene. Expr. 6, 115–138.10.1615/CritRevEukarGeneExpr.v6.i2-3.20Search in Google Scholar

Bonilla Guerrero, R. and Roberts, L.R. (2005). The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J. Hepatol. 42, 760–777.10.1016/j.jhep.2005.02.005Search in Google Scholar PubMed

Boudreau, H.E., Emerson, S.U., Korzeniowska, A., Jendrysik, M.A., and Leto, T.L. (2009). Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. J. Virol. 83, 12934–12946.10.1128/JVI.01059-09Search in Google Scholar PubMed PubMed Central

Boulikas, T. (1993). Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J. Cell Biochem. 52, 14–22.10.1002/jcb.240520104Search in Google Scholar PubMed

Boyault, S., Rickman, D.S., de Reynies, A., Balabaud, C., Rebouissou, S., Jeannot, E., Herault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007). Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45, 42–52.10.1002/hep.21467Search in Google Scholar PubMed

Bralet, M.P., Calise, D., Brechot, C., and Ferry, N. (1996). In vivo cell lineage analysis during chemical hepatocarcinogenesis using retroviral-mediated gene transfer. Lab. Invest. 74, 871–881.Search in Google Scholar

Brechot, C. (2004). Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127, S56–S61.10.1053/j.gastro.2004.09.016Search in Google Scholar PubMed

Brechot, C., Kremsdorf, D., Soussan, P., Pineau, P., Dejean, A., Paterlini-Brechot, P., and Tiollais, P. (2010). Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms. Pathol. Biol. (Paris) 58, 278–28710.1016/j.patbio.2010.05.001Search in Google Scholar

Bruni, R., D’Ugo, E., Argentini, C., Giuseppetti, R., and Rapicetta, M. (2003). Scaffold attachment region located in a locus targeted by hepadnavirus integration in hepatocellular carcinomas. Cancer Detect. Prev. 27, 175–181.10.1016/S0361-090X(03)00061-8Search in Google Scholar

Bruni, R., D’Ugo, E., Giuseppetti, R., Argentini, C., and Rapicetta, M. (1999). Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma. Virology 257, 483–490.10.1006/viro.1999.9678Search in Google Scholar

Buhler, S. and Bartenschlager, R. (2011). Molecular mechanisms of hepatitis C virus (HCV) replication - implications for the development of antiviral drugs. Z. Gastroenterol. 49, 836–844.10.1055/s-0031-1273196Search in Google Scholar

Bukh, J. (2016). The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control. J. Hepatol. 65, S2–S21.10.1016/j.jhep.2016.07.035Search in Google Scholar

Bureau, C., Bernad, J., Chaouche, N., Orfila, C., Beraud, M., Gonindard, C., Alric, L., Vinel, J.P., and Pipy, B. (2001). Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J. Biol. Chem. 276, 23077–23083.10.1074/jbc.M100698200Search in Google Scholar

Cameron, R.G. (1989). Identification of the putative first cellular step of chemical hepatocarcinogenesis. Cancer Lett. 47, 163–167.10.1016/0304-3835(89)90086-4Search in Google Scholar

Chang, M.L. (2016). Metabolic alterations and hepatitis C: From bench to bedside. World J. Gastroenterol. 22, 1461–1476.10.3748/wjg.v22.i4.1461Search in Google Scholar PubMed PubMed Central

Chang, P.C., Chi, C.W., Chau, G.Y., Li, F.Y., Tsai, Y.H., Wu, J.C., and Wu Lee, Y.H. (2006). DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 25, 1991–2003.10.1038/sj.onc.1209239Search in Google Scholar PubMed

Chao, C.H., Chen, C.M., Cheng, P.L., Shih, J.W., Tsou, A.P., and Lee, Y.H. (2006). DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res. 66, 6579–6588.10.1158/0008-5472.CAN-05-2415Search in Google Scholar PubMed

Chen, C.J., Yang, H.I., Su, J., Jen, C.L., You, S.L., Lu, S.N., Huang, G.T., Iloeje, U.H., and Group, R.-H.S. (2006). Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. J. Am. Med. Assoc. 295, 65–73.10.1001/jama.295.1.65Search in Google Scholar PubMed

Chen, J., Wu, M., Wang, F., Zhang, W., Wang, W., Zhang, X., Zhang, J., Liu, Y., Liu, Y., Feng, Y., et al. (2015). Hepatitis B virus spliced variants are associated with an impaired response to interferon therapy. Sci. Rep. 5, 16459.10.1038/srep16459Search in Google Scholar PubMed PubMed Central

Chen, R., Rabinovitch, P.S., Crispin, D.A., Emond, M.J., Bronner, M.P., and Brentnall, T.A. (2005). The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 26, 1513–1519.10.1093/carcin/bgi106Search in Google Scholar PubMed

Cheng, P.L., Chang, M.H., Chao, C.H., and Lee, Y.H. (2004). Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-β/Smad3-mediated transcriptional activation. Oncogene 23, 7821–7838.10.1038/sj.onc.1208066Search in Google Scholar PubMed

Chisari, F.V., Filippi, P., Buras, J., McLachlan, A., Popper, H., Pinkert, C.A., Palmiter, R.D., and Brinster, R.L. (1987). Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. USA 84, 6909–6913.10.1073/pnas.84.19.6909Search in Google Scholar PubMed PubMed Central

Choi, J., Corder, N.L., Koduru, B., and Wang, Y. (2014). Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma. Free Radic. Biol. Med. 72, 267–284.10.1016/j.freeradbiomed.2014.04.020Search in Google Scholar PubMed PubMed Central

Conti, F., Buonfiglioli, F., Scuteri, A., Crespi, C., Bolondi, L., Caraceni, P., Foschi, F.G., Lenzi, M., Mazzella, G., Verucchi, G., et al. (2016). Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J. Hepatol. 65, 727–733.10.1016/j.jhep.2016.06.015Search in Google Scholar PubMed

Coulouarn, C., Factor, V.M., Andersen, J.B., Durkin, M.E., and Thorgeirsson, S.S. (2009). Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28, 3526–3536.10.1038/onc.2009.211Search in Google Scholar PubMed PubMed Central

Dandri, M., Burda, M.R., Burkle, A., Zuckerman, D.M., Will, H., Rogler, C.E., Greten, H., and Petersen, J. (2002). Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology 35, 217–223.10.1053/jhep.2002.30203Search in Google Scholar PubMed

de Mochel, N.S., Seronello, S., Wang, S.H., Ito, C., Zheng, J.X., Liang, T.J., Lambeth, J.D., and Choi, J. (2010). Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 52, 47–59.10.1002/hep.23671Search in Google Scholar PubMed PubMed Central

Decorsiere, A., Mueller, H., van Breugel, P.C., Abdul, F., Gerossier, L., Beran, R.K., Livingston, C.M., Niu, C., Fletcher, S.P., Hantz, O., et al. (2016). Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. Nature 531, 386–389.10.1038/nature17170Search in Google Scholar PubMed

Dharel, N., Kato, N., Muroyama, R., Taniguchi, H., Otsuka, M., Wang, Y., Jazag, A., Shao, R.X., Chang, J.H., Adler, M.K., et al. (2008). Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus. Hepatology 47, 1136–1149.10.1002/hep.22176Search in Google Scholar PubMed

Dion, S., Bourgine, M., Godon, O., Levillayer, F., and Michel, M.L. (2013). Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. J. Virol. 87, 5554–5563.10.1128/JVI.03134-12Search in Google Scholar PubMed PubMed Central

Dorner, M., Horwitz, J.A., Donovan, B.M., Labitt, R.N., Budell, W.C., Friling, T., Vogt, A., Catanese, M.T., Satoh, T., Kawai, T., et al. (2013). Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 501, 237–241.10.1038/nature12427Search in Google Scholar PubMed PubMed Central

EASL (2012). EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J. Hepatol. 57, 167–185.10.1016/j.jhep.2012.02.010Search in Google Scholar PubMed

El-Serag, H.B., Kanwal, F., Richardson, P., and Kramer, J. (2016). Risk of hepatocellular carcinoma after sustained virological response in veterans with hepatitis C virus infection. Hepatology 64, 130–137.10.1002/hep.28535Search in Google Scholar PubMed PubMed Central

Fan, Y.F., Lu, C.C., Chen, W.C., Yao, W.J., Wang, H.C., Chang, T.T., Lei, H.Y., Shiau, A.L., and Su, I.J. (2001). Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33, 277–286.10.1053/jhep.2001.21163Search in Google Scholar PubMed

Farinati, F., Piciocchi, M., Lavezzo, E., Bortolami, M., and Cardin, R. (2010). Oxidative stress and inducible nitric oxide synthase induction in carcinogenesis. Dig. Dis. 28, 579–584.10.1159/000320052Search in Google Scholar PubMed

Fattovich, G., Bortolotti, F., Donato, F. (2008). Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J. Hepatol. 48, 335–352.10.1016/j.jhep.2007.11.011Search in Google Scholar PubMed

Fattovich, G., Giustina, G., Christensen, E., Pantalena, M., Zagni, I., Realdi, G., and Schalm, S.W. (2000). Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut. 46, 420–426.10.1136/gut.46.3.420Search in Google Scholar PubMed PubMed Central

Fattovich, G., Stroffolini, T., Zagni, I., and Donato, F. (2004). Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127, S35–S50.10.1053/j.gastro.2004.09.014Search in Google Scholar PubMed

Feo, F., Frau, M., Tomasi, M.L., Brozzetti, S., and Pascale, R.M. (2009). Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma. Exp. Biol. Med. (Maywood) 234, 726–736.10.3181/0901-MR-40Search in Google Scholar PubMed

Fuchs, B.C., Hoshida, Y., Fujii, T., Wei, L., Yamada, S., Lauwers, G.Y., McGinn, C.M., DePeralta, D.K., Chen, X., Kuroda, T., Lanuti, M., et al. (2014). Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology 59, 1577–1590.10.1002/hep.26898Search in Google Scholar PubMed PubMed Central

Fujimoto, A., Furuta, M., Totoki, Y., Tsunoda, T., Kato, M., Shiraishi, Y., Tanaka, H., Taniguchi, H., Kawakami, Y., Ueno, M., et al. (2016). Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat. Genet. 48, 500–509.10.1038/ng.3547Search in Google Scholar PubMed

Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P., and Charnay, P. (1979). Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281, 646–650.10.1038/281646a0Search in Google Scholar PubMed

Giannelli, G., Quaranta, V., and Antonaci, S. (2003). Tissue remodelling in liver diseases. Histol. Histopathol. 18, 1267–1274.Search in Google Scholar

Giersch, K., Allweiss, L., Volz, T., Helbig, M., Bierwolf, J., Lohse, A.W., Pollok, J.M., Petersen, J., Dandri, M., and Lutgehetmann, M. (2015). Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. J. Hepatol. 63, 346–353.10.1016/j.jhep.2015.03.011Search in Google Scholar PubMed

Gissen, P. and Arias, I.M. (2015). Structural and functional hepatocyte polarity and liver disease. J. Hepatol. 63, 1023–1037.10.1016/j.jhep.2015.06.015Search in Google Scholar PubMed PubMed Central

Gong, G., Waris, G., Tanveer, R., and Siddiqui, A. (2001). Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. USA 98, 9599–9604.10.1073/pnas.171311298Search in Google Scholar PubMed PubMed Central

Gong, L., Li, Y.H., Su, Q., Chu, X., and Zhang, W. (2010). Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes. Histopathology 56, 589–599.10.1111/j.1365-2559.2010.03523.xSearch in Google Scholar PubMed

Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I.B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012). Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 44, 694–698.10.1038/ng.2256Search in Google Scholar PubMed PubMed Central

Guidotti, L.G., Matzke, B., Schaller, H., and Chisari, F.V. (1995). High-level hepatitis B virus replication in transgenic mice. J. Virol. 69, 6158–6169.10.1128/jvi.69.10.6158-6169.1995Search in Google Scholar

Guilhot, S., Huang, S.N., Xia, Y.P., La Monica, N., Lai, M.M., and Chisari, F.V. (1994). Expression of the hepatitis delta virus large and small antigens in transgenic mice. J. Virol. 68, 1052–1058.10.1128/jvi.68.2.1052-1058.1994Search in Google Scholar

Gunther, S., Sommer, G., Iwanska, A., and Will, H. (1997). Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA. Virology 238, 363–371.10.1006/viro.1997.8863Search in Google Scholar PubMed

Halpern, K.B., Shenhav, R., Matcovitch-Natan, O., Toth, B., Lemze, D., Golan, M., Massasa, E.E., Baydatch, S., Landen, S., Moor, A.E., et al. (2017). Single-cell spatial reconstruction reveals global division of labour in the mammalian liver. Nature 542, 352–356.10.1038/nature21065Search in Google Scholar PubMed PubMed Central

Harris, R.J., Thomas, B., Griffiths, J., Costella, A., Chapman, R., Ramsay, M., De Angelis, D., and Harris, H.E. (2014). Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios. J. Hepatol. 61, 530–s537.10.1016/j.jhep.2014.05.008Search in Google Scholar PubMed

He, J., Zhao, K., Zheng, L., Xu, Z., Gong, W., Chen, S., Shen, X., Huang, G., Gao, M., Zeng, Y., et al. (2015a). Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells. Mol. Cancer. 14, 163.10.1186/s12943-015-0427-9Search in Google Scholar PubMed PubMed Central

He, W., Ren, B., Mao, F., Jing, Z., Li, Y., Liu, Y., Peng, B., Yan, H., Qi, Y., Sun, Y., et al. (2015b). Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide. PLoS Pathog. 11, e1004840.10.1371/journal.ppat.1004840Search in Google Scholar PubMed PubMed Central

He, Y., Nakao, H., Tan, S.L., Polyak, S.J., Neddermann, P., Vijaysri, S., Jacobs, B.L., and Katze, M.G. (2002). Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J. Virol. 76, 9207–9217.10.1128/JVI.76.18.9207-9217.2002Search in Google Scholar

Heim, M.H. and Thimme, R. (2014). Innate and adaptive immune responses in HCV infections. J. Hepatol. 61, S14–S25.10.1016/j.jhep.2014.06.035Search in Google Scholar PubMed

Herath, N.I., Leggett, B.A., and MacDonald, G.A. (2006). Review of genetic and epigenetic alterations in hepatocarcinogenesis. J. Gastroenterol. Hepatol. 21, 15–21.10.1111/j.1440-1746.2005.04043.xSearch in Google Scholar PubMed

Higgs, M.R., Chouteau, P., and Lerat, H. (2014.) ’Liver let die’: oxidative DNA damage and hepatotropic viruses. J. Gen. Virol. 95, 991–1004.10.1099/vir.0.059485-0Search in Google Scholar PubMed

Hsu, S.H., Wang, B., Kota, J., Yu, J., Costinean, S., Kutay, H., Yu, L., Bai, S., La Perle, K., Chivukula, R.R., et al. (2012). Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122, 2871–2883.10.1172/JCI63539Search in Google Scholar PubMed PubMed Central

Huang, H., Shiffman, M.L., Cheung, R.C., Layden, T.J., Friedman, S., Abar, O.T., Yee, L., Chokkalingam, A.P., Schrodi, S.J., Chan, J., et al. (2006a). Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology 130, 1679–1687.10.1053/j.gastro.2006.02.032Search in Google Scholar PubMed

Huang, L.R., Wu, H.L., Chen, P.J., and Chen, D.S. (2006b). An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 103, 17862–17867.10.1073/pnas.0608578103Search in Google Scholar PubMed PubMed Central

Huang, J., Deng, Q., Wang, Q., Li, K.Y., Dai, J.H., Li, N., Zhu, Z.D., Zhou, B., Liu, X.Y., Liu, R.F., et al. (2012). Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat. Genet. 44, 1117–1121.10.1038/ng.2391Search in Google Scholar PubMed

Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M.M., Ellis, E., van Wenum, M., Fuchs, S.A., de Ligt, J., et al. (2015). Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299–312.10.1016/j.cell.2014.11.050Search in Google Scholar PubMed PubMed Central

Ivanov, A.V., Bartosch, B., Smirnova, O.A., Isaguliants, M.G., and Kochetkov, S.N. (2013). HCV and oxidative stress in the liver. Viruses 5, 439–469.10.3390/v5020439Search in Google Scholar PubMed PubMed Central

Jacob, J.R., Sterczer, A., Toshkov, I.A., Yeager, A.E., Korba, B.E., Cote, P.J., Buendia, M.A., Gerin, J.L., and Tennant, B.C. (2004). Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors. Hepatology 39, 1008–1016.10.1002/hep.20106Search in Google Scholar PubMed

Jiang, S., Yang, Z., Li, W., Li, X., Wang, Y., Zhang, J., Xu, C., Chen, P.J., Hou, J., McCrae, M.A., et al. (2012a). Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. PLoS One 7, e40363.10.1371/journal.pone.0040363Search in Google Scholar PubMed PubMed Central

Jiang, Z., Jhunjhunwala, S., Liu, J., Haverty, P.M., Kennemer, M.I., Guan, Y., Lee, W., Carnevali, P., Stinson, J., Johnson, S., et al. (2012b). The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome. Res. 22, 593–601.10.1101/gr.133926.111Search in Google Scholar PubMed PubMed Central

Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M., and Sarnow, P. (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309, 1577–1581.10.1126/science.1113329Search in Google Scholar

Kao, J.H. (2015). Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Pract. Res. Clin. Gastroenterol. 29, 907–917.10.1016/j.bpg.2015.09.011Search in Google Scholar

Kawanishi, S. and Hiraku, Y. (2006). Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid. Redox. Signal. 8, 1047–1058.10.1089/ars.2006.8.1047Search in Google Scholar

Kennedy, P.T., Sandalova, E., Jo, J., Gill, U., Ushiro-Lumb, I., Tan, A.T., Naik, S., Foster, G.R., and Bertoletti, A. (2012). Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology 143, 637–645.10.1053/j.gastro.2012.06.009Search in Google Scholar

Kew, M.C., 1989. Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks. Gastroenterology 97, 136–139.10.1016/0016-5085(89)91426-1Search in Google Scholar

Kosaka, K., Hiraga, N., Imamura, M., Yoshimi, S., Murakami, E., Nakahara, T., Honda, Y., Ono, A., Kawaoka, T., Tsuge, M., et al. (2013). A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Biochem. Biophys. Res. Commun. 441, 230–235.10.1016/j.bbrc.2013.10.040Search in Google Scholar PubMed

Kozbial, K., Moser, S., Schwarzer, R., Laferl, H., Al-Zoairy, R., Stauber, R., Stattermayer, A.F., Beinhardt, S., Graziadei, I., Freissmuth, C., et al. (2016). Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment. J. Hepatol. 65, 856–858.10.1016/j.jhep.2016.06.009Search in Google Scholar PubMed

Kutay, H., Bai, S., Datta, J., Motiwala, T., Pogribny, I., Frankel, W., Jacob, S.T., and Ghoshal, K. (2006). Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem. 99, 671–678.10.1002/jcb.20982Search in Google Scholar PubMed PubMed Central

Lai, M., Hyatt, B.J., Nasser, I., Curry, M., and Afdhal, N.H. (2007). The clinical significance of persistently normal ALT in chronic hepatitis B infection. J. Hepatol. 47, 760–767.10.1016/j.jhep.2007.07.022Search in Google Scholar PubMed

Lakhtakia, R., Kumar, V., Reddi, H., Mathur, M., Dattagupta, S., and Panda, S.K. (2003). Hepatocellular carcinoma in a hepatitis B ’x’ transgenic mouse model: A sequential pathological evaluation. J. Gastroenterol. Hepatol. 18, 80–91.10.1046/j.1440-1746.2003.02902.xSearch in Google Scholar PubMed

Lan, K.H., Sheu, M.L., Hwang, S.J., Yen, S.H., Chen, S.Y., Wu, J.C., Wang, Y.J., Kato, N., Omata, M., Chang, F.Y., and Lee, S.D. (2002). HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 21, 4801–4811.10.1038/sj.onc.1205589Search in Google Scholar PubMed

Lee, J.S. (2015). The mutational landscape of hepatocellular carcinoma. Clin. Mol. Hepatol. 21, 220–229.10.3350/cmh.2015.21.3.220Search in Google Scholar PubMed PubMed Central

Lempp, F.A., Wiedtke, E., Qu, B., Roques, P., Chemin, I., Vondran, F.W., Le Grand, R., Grimm, D., and Urban, S. (2017). Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B Virus infection in macaque and pig hepatocytes. Hepatology. Doi: 10.1002/hep.29112 [Epub ahead of print].10.1002/hep.29112Search in Google Scholar PubMed

Levy, L., Renard, C.A., Wei, Y., and Buendia, M.A. (2002). Genetic alterations and oncogenic pathways in hepatocellular carcinoma. Ann. N. Y. Acad. Sci. 963, 21–36.10.1111/j.1749-6632.2002.tb04091.xSearch in Google Scholar PubMed

Li, H., Zhuang, Q., Wang, Y., Zhang, T., Zhao, J., Zhang, Y., Zhang, J., Lin, Y., Yuan, Q., Xia, N., et al. (2014). HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol. Immunol. 11, 175–183.10.1038/cmi.2013.66Search in Google Scholar PubMed PubMed Central

Li, Q., Pene, V., Krishnamurthy, S., Cha, H., and Liang, T.J. (2013). Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly. Nat. Med. 19, 722–729.10.1038/nm.3190Search in Google Scholar PubMed PubMed Central

Li, Y., Tang, Z.Y., and Hou, J.X. (2012). Hepatocellular carcinoma: insight from animal models. Nat Rev Gastroenterol. Hepatol. 9, 32–43.10.1038/nrgastro.2011.196Search in Google Scholar PubMed

Lin, N., Chen, H.Y., Li, D., Zhang, S.J., Cheng, Z.X., and Wang, X.Z. (2005). Apoptosis and its pathway in X gene-transfected HepG2 cells. World J. Gastroenterol. 11, 4326–4331.10.3748/wjg.v11.i28.4326Search in Google Scholar PubMed PubMed Central

Liu, Q.Y., Ribecco-Lutkiewicz, M., Carson, C., Testolin, L., Bergeron, D., Kohwi-Shigematsu, T., Walker, P.R., and Sikorska, M. (2003). Mapping the initial DNA breaks in apoptotic Jurkat cells using ligation-mediated PCR. Cell Death Differ. 10, 278–289.10.1038/sj.cdd.4401146Search in Google Scholar PubMed

Liu, S., Zhang, H., Gu, C., Yin, J., He, Y., Xie, J., and Cao, G. (2009a). Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J. Natl. Cancer Inst. 101, 1066–1082.10.1093/jnci/djp180Search in Google Scholar PubMed PubMed Central

Liu, S., Zhang, H., Gu, C., Yin, J., He, Y., Xie, J., and Cao, G. (2009b). Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J. Natl. Cancer Inst. 101, 1066–1082.10.1093/jnci/djp180Search in Google Scholar PubMed PubMed Central

Lohmann, V. (2013). Hepatitis C virus RNA replication. Curr. Top. Microbiol. Immunol. 369, 167–198.10.1007/978-3-642-27340-7_7Search in Google Scholar PubMed PubMed Central

Lonardo, A., Adinolfi, L.E., Restivo, L., Ballestri, S., Romagnoli, D., Baldelli, E., Nascimbeni, F., and Loria, P. (2014). Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen. World J. Gastroenterol. 20, 7089–7103.10.3748/wjg.v20.i23.7089Search in Google Scholar PubMed PubMed Central

Luna, J.M., Scheel, T.K., Danino, T., Shaw, K.S., Mele, A., Fak, J.J., Nishiuchi, E., Takacs, C.N., Catanese, M.T., de Jong, Y.P., et al. (2015). Hepatitis C virus RNA functionally sequesters miR-122. Cell 160, 1099–1110.10.1016/j.cell.2015.02.025Search in Google Scholar PubMed PubMed Central

Lupberger, J., Zeisel, M.B., Xiao, F., Thumann, C., Fofana, I., Zona, L., Davis, C., Mee, C.J., Turek, M., Gorke, S., et al. (2011). EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 17, 589–595.10.1038/nm.2341Search in Google Scholar PubMed PubMed Central

Ma, N.F., Lau, S.H., Hu, L., Xie, D., Wu, J., Yang, J., Wang, Y., Wu, M.C., Fung, J., Bai, X., et al. (2008). COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin. Cancer Res. 14, 5061–5068.10.1158/1078-0432.CCR-07-5082Search in Google Scholar PubMed

Machida, K., Liu, J.C., McNamara, G., Levine, A., Duan, L., and Lai, M.M. (2009). Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J. Virol. 83, 12590–s12600.10.1128/JVI.02643-08Search in Google Scholar PubMed PubMed Central

Malato, Y., Naqvi, S., Schurmann, N., Ng, R., Wang, B., Zape, J., Kay, M.A., Grimm, D., and Willenbring, H. (2011). Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J. Clin. Invest. 121, 4850–4860.10.1172/JCI59261Search in Google Scholar PubMed PubMed Central

Marion, P.L., Knight, S.S., Ho, B.K., Guo, Y.Y., Robinson, W.S., and Popper, H. (1984). Liver disease associated with duck hepatitis B virus infection of domestic ducks. Proc. Natl. Acad. Sci. USA 81, 898–902.10.1073/pnas.81.3.898Search in Google Scholar PubMed PubMed Central

Marongiu, F., Doratiotto, S., Montisci, S., Pani, P., and Laconi, E. (2008). Liver repopulation and carcinogenesis: two sides of the same coin? Am. J. Pathol. 172, 857–864.10.2353/ajpath.2008.070910Search in Google Scholar PubMed PubMed Central

Marschenz, S., Endres, A.S., Brinckmann, A., Heise, T., Kristiansen, G., Nurnberg, P., Kruger, D.H., Gunther, S., and Meisel, H. (2006). Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology 131, 765–780.10.1053/j.gastro.2006.07.008Search in Google Scholar PubMed

Martin, B., Hennecke, N., Lohmann, V., Kayser, A., Neumann-Haefelin, C., Kukolj, G., Bocher, W.O., and Thimme, R. (2014). Restoration of HCV-specific CD8+ T cell function by interferon-free therapy. J. Hepatol. 61, 538–543.10.1016/j.jhep.2014.05.043Search in Google Scholar PubMed

Mason, W.S., Gill, U.S., Litwin, S., Zhou, Y., Peri, S., Pop, O., Hong, M.L., Naik, S., Quaglia, A., Bertoletti, A., et al. (2016). HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant. Gastroenterology 151, 986–998.e4.10.1053/j.gastro.2016.07.012Search in Google Scholar PubMed PubMed Central

Mazza, G., Rombouts, K., Rennie Hall, A., Urbani, L., Vinh Luong, T., Al-Akkad, W., Longato, L., Brown, D., Maghsoudlou, P., Dhillon, A.P., et al. (2015). Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. Sci Rep 5, 13079.10.1038/srep13079Search in Google Scholar PubMed PubMed Central

McGivern, D.R. and Lemon, S.M. (2011). Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30, 1969–1983.10.1038/onc.2010.594Search in Google Scholar PubMed PubMed Central

Merlo, L.M., Shah, N.A., Li, X., Blount, P.L., Vaughan, T.L., Reid, B.J., and Maley, C.C. (2010). A comprehensive survey of clonal diversity measures in Barrett’s esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev. Res. (Phila.) 3, 1388–1397.10.1158/1940-6207.CAPR-10-0108Search in Google Scholar PubMed PubMed Central

Meuleman, P., Libbrecht, L., De Vos, R., de Hemptinne, B., Gevaert, K., Vandekerckhove, J., Roskams, T., and Leroux-Roels, G. (2005). Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41, 847–856.10.1002/hep.20657Search in Google Scholar PubMed

Morgan, R.L., Baack, B., Smith, B.D., Yartel, A., Pitasi, M., and Falck-Ytter, Y. (2013). Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann. Intern. Med. 158, 329–337.10.7326/0003-4819-158-5-201303050-00005Search in Google Scholar PubMed

Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., and Koike, K. (1998). The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4, 1065–1067.10.1038/2053Search in Google Scholar PubMed

Moriya, K., Nakagawa, K., Santa, T., Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Miyazawa, T., Ishibashi, K., Horie, T., et al. (2001). Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 61, 4365–4370.Search in Google Scholar

Munakata, T., Liang, Y., Kim, S., McGivern, D.R., Huibregtse, J., Nomoto, A., and Lemon, S.M. (2007). Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog. 3, 1335–1347.10.1371/journal.ppat.0030139Search in Google Scholar PubMed PubMed Central

Munakata, T., Nakamura, M., Liang, Y., Li, K., and Lemon, S.M. (2005). Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc. Natl. Acad. Sci. USA 102, 18159–18164.10.1073/pnas.0505605102Search in Google Scholar PubMed PubMed Central

Murdoch, C. and Lewis, C.E. (2005). Macrophage migration and gene expression in response to tumor hypoxia. Int. J. Cancer. 117, 701–708.10.1002/ijc.21422Search in Google Scholar PubMed

Nakagawa, H. and Maeda, S. (2012). Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK. Patholog. Res. Int. 2012, 172894.10.1155/2012/172894Search in Google Scholar PubMed PubMed Central

Nakamoto, Y., Guidotti, L.G., Kuhlen, C.V., Fowler, P., and Chisari, F.V. (1998). Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med. 188, 341–350.10.1084/jem.188.2.341Search in Google Scholar PubMed PubMed Central

Nault, J.C., Mallet, M., Pilati, C., Calderaro, J., Bioulac-Sage, P., Laurent, C., Laurent, A., Cherqui, D., Balabaud, C., and Zucman Rossi, J. (2013). High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat. Commun. 4, 2218.10.1038/ncomms3218Search in Google Scholar PubMed PubMed Central

Negro, F. (2014). Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases. J. Hepatol. 61, S69–S78.10.1016/j.jhep.2014.08.003Search in Google Scholar PubMed

Ng, K.Y., Chai, S., Tong, M., Guan, X.Y., Lin, C.H., Ching, Y.P., Xie, D., Cheng, A.S., and Ma, S. (2016). C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. Oncotarget 7, 24005–24017.10.18632/oncotarget.8209Search in Google Scholar PubMed PubMed Central

Ni, Y., Lempp, F.A., Mehrle, S., Nkongolo, S., Kaufman, C., Falth, M., Stindt, J., Koniger, C., Nassal, M., Kubitz, R., et al. (2014). Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146, 1070–1083.10.1053/j.gastro.2013.12.024Search in Google Scholar PubMed

Nishida, N. and Goel, A. (2011). Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr. Genomics 12, 130–137.10.2174/138920211795564359Search in Google Scholar PubMed PubMed Central

Nogueira, V. and Hay, N. (2013). Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin. Cancer Res. 19, 4309–4314.10.1158/1078-0432.CCR-12-1424Search in Google Scholar PubMed PubMed Central

Ohshima, K., Ohgami, A., Matsuoka, M., Etoh, K., Utsunomiya, A., Makino, T., Ishiguro, M., Suzumiya, J., and Kikuchi, M. (1998). Random integration of HTLV-1 provirus: increasing chromosomal instability. Cancer Lett. 132, 203–212.10.1016/S0304-3835(98)00188-8Search in Google Scholar

Otsuka, M., Kato, N., Lan, K., Yoshida, H., Kato, J., Goto, T., Shiratori, Y., and Omata, M. (2000). Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 275, 34122–34130.10.1074/jbc.M000578200Search in Google Scholar PubMed

Owsianka, A.M. and Patel, A.H. (1999). Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 257, 330–340.10.1006/viro.1999.9659Search in Google Scholar PubMed

Pasquinelli, C., Bhavani, K. and Chisari, F.V. (1992). Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res. 52, 2823–2829.Search in Google Scholar

Paterlini-Brechot, P., Saigo, K., Murakami, Y., Chami, M., Gozuacik, D., Mugnier, C., Lagorce, D., and Brechot, C. (2003). Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22, 3911–3916.10.1038/sj.onc.1206492Search in Google Scholar PubMed

Paul, D., Madan, V., and Bartenschlager, R. (2014). Hepatitis C virus RNA replication and assembly: living on the fat of the land. Cell Host. Microbe. 16, 569–579.10.1016/j.chom.2014.10.008Search in Google Scholar PubMed PubMed Central

Pavio, N., Battaglia, S., Boucreux, D., Arnulf, B., Sobesky, R., Hermine, O., and Brechot, C. (2005). Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-β pathway. Oncogene 24, 6119–6132.10.1038/sj.onc.1208749Search in Google Scholar PubMed

Pawlotsky, J.M., Feld, J.J., Zeuzem, S., and Hoofnagle, J.H. (2015). From non-A, non-B hepatitis to hepatitis C virus cure. J. Hepatol. 62, S87–S99.10.1016/j.jhep.2015.02.006Search in Google Scholar PubMed

Pekow, J.R., Bhan, A.K., Zheng, H., and Chung, R.T. (2007). Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 109, 2490–2496.10.1002/cncr.22701Search in Google Scholar PubMed

Pett, M.R., Alazawi, W.O., Roberts, I., Dowen, S., Smith, D.I., Stanley, M.A., and Coleman, N. (2004). Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res. 64, 1359–1368.10.1158/0008-5472.CAN-03-3214Search in Google Scholar PubMed

Pol, S., Bourliere, M., Lucier, S., Hezode, C., Dorival, C., Larrey, D., Bronowicki, J.P., Ledinghen, V.D., Zoulim, F., Tran, A., et al. (2017). Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. J. Hepatol. 66, 39–47.10.1016/j.jhep.2016.08.021Search in Google Scholar PubMed

Pollicino, T. and Saitta, C. (2014). Occult hepatitis B virus and hepatocellular carcinoma. World J. Gastroenterol. 20, 5951–5961.10.3748/wjg.v20.i20.5951Search in Google Scholar PubMed PubMed Central

Pollicino, T., Saitta, C., and Raimondo, G. (2011). Hepatocellular carcinoma: the point of view of the hepatitis B virus. Carcinogenesis 32, 1122–1132.10.1093/carcin/bgr108Search in Google Scholar PubMed

Popper, H., Roth, L., Purcell, R.H., Tennant, B.C., and Gerin, J.L. (1987). Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc. Natl. Acad. Sci. USA 84, 866–870.10.1073/pnas.84.3.866Search in Google Scholar PubMed PubMed Central

Qu, Z.L., Zou, S.Q., Cui, N.Q., Wu, X.Z., Qin, M.F., Kong, D., and Zhou, Z.L. (2005). Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells. World J. Gastroenterol. 11, 5627–5632.10.3748/wjg.v11.i36.5627Search in Google Scholar PubMed PubMed Central

Quinkert, D., Bartenschlager, R., and Lohmann, V. (2005). Quantitative analysis of the hepatitis C virus replication complex. J. Virol. 79, 13594–13605.10.1128/JVI.79.21.13594-13605.2005Search in Google Scholar PubMed PubMed Central

Reig, M., Marino, Z., Perello, C., Inarrairaegui, M., Ribeiro, A., Lens, S., Diaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016). Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J. Hepatol. 65, 719–726.10.1016/j.jhep.2016.04.008Search in Google Scholar PubMed

Rosmorduc, O., Petit, M.A., Pol, S., Capel, F., Bortolotti, F., Berthelot, P., Brechot, C., and Kremsdorf, D. (1995). In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology 22, 10–19.Search in Google Scholar

Ruggieri, A., Dazert, E., Metz, P., Hofmann, S., Bergeest, J.P., Mazur, J., Bankhead, P., Hiet, M.S., Kallis, S., Alvisi, G., et al. (2012). Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection. Cell Host. Microbe. 12, 71–85.10.1016/j.chom.2012.05.013Search in Google Scholar PubMed PubMed Central

Rupp, D. and Bartenschlager, R. (2014). Targets for antiviral therapy of hepatitis C. Semin. Liver Dis. 34, 9–21.10.1055/s-0034-1371006Search in Google Scholar PubMed

Scheel, T.K., Luna, J.M., Liniger, M., Nishiuchi, E., Rozen-Gagnon, K., Shlomai, A., Auray, G., Gerber, M., Fak, J., Keller, I., et al. (2016). A broad RNA virus survey reveals both miRNA dependence and functional sequestration. Cell Host. Microbe. 19, 409–423.10.1016/j.chom.2016.02.007Search in Google Scholar PubMed PubMed Central

Schulze, A., Gripon, P., and Urban, S. (2007). Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46, 1759–1768.10.1002/hep.21896Search in Google Scholar PubMed

Schulze, K., Imbeaud, S., Letouze, E., Alexandrov, L.B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015). Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47, 505–511.10.1038/ng.3252Search in Google Scholar

Seitz, S., Iancu, C., Volz, T., Mier, W., Dandri, M., Urban, S., and Bartenschlager, R. (2016). A slow maturation process renders hepatitis B virus infectious. Cell Host. Microbe. 20, 25–35.10.1016/j.chom.2016.05.013Search in Google Scholar

Shera, K.A., Shera, C.A., and McDougall, J.K. (2001). Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells. J. Virol. 75, 12339–12346.10.1128/JVI.75.24.12339-12346.2001Search in Google Scholar

Slagle, B.L., Andrisani, O.M., Bouchard, M.J., Lee, C.G., Ou, J.H., and Siddiqui, A. (2015). Technical standards for hepatitis B virus X protein (HBx) research. Hepatology 61, 1416–1424.10.1002/hep.27360Search in Google Scholar

Smirnova, O.A., Ivanova, O.N., Bartosch, B., Valuev-Elliston, V.T., Mukhtarov, F., Kochetkov, S.N., and Ivanov, A.V. (2016). Hepatitis C virus NS5A protein triggers oxidative stress by inducing NADPH oxidases 1 and 4 and cytochrome P450 2E1. Oxid. Med. Cell. Longev. 2016, 8341937.10.1155/2016/8341937Search in Google Scholar

Smith, D.B., Bukh, J., Kuiken, C., Muerhoff, A.S., Rice, C.M., Stapleton, J.T., and Simmonds, P. (2014). Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59, 318–327.10.1002/hep.26744Search in Google Scholar

Song, K., Han, C., Zhang, J., Lu, D., Dash, S., Feitelson, M., Lim, K., and Wu, T. (2013). Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis B virus X protein in hepatocellular carcinoma cells. Hepatology 58, 1681–1692.10.1002/hep.26514Search in Google Scholar

Soussan, P., Tuveri, R., Nalpas, B., Garreau, F., Zavala, F., Masson, A., Pol, S., Brechot, C., and Kremsdorf, D. (2003). The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J. Hepatol. 38, 343–348.10.1016/S0168-8278(02)00422-1Search in Google Scholar

Street, A., Macdonald, A., McCormick, C., and Harris, M. (2005). Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J. Virol. 79, 5006–5016.10.1128/JVI.79.8.5006-5016.2005Search in Google Scholar PubMed PubMed Central

Strick-Marchand, H., Dusseaux, M., Darche, S., Huntington, N.D., Legrand, N., Masse-Ranson, G., Corcuff, E., Ahodantin, J., Weijer, K., Spits, H., et al. (2015). A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS One 10, e0119820.10.1371/journal.pone.0119820Search in Google Scholar PubMed PubMed Central

Su, I.J., Wang, H.C., Wu, H.C., and Huang, W.Y. (2008). Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 23, 1169–1174.10.1111/j.1440-1746.2008.05348.xSearch in Google Scholar

Su, Q. and Bannasch, P. (2003). Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol. Pathol. 31, 126–133.10.1080/01926230309732Search in Google Scholar

Sumida, Y., Nakashima, T., Yoh, T., Nakajima, Y., Ishikawa, H., Mitsuyoshi, H., Sakamoto, Y., Okanoue, T., Kashima, K., Nakamura, H., et al. (2000). Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J. Hepatol. 33, 616–622.10.1016/S0168-8278(00)80013-6Search in Google Scholar

Sung, W.K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N.P., Lee, W.H., Ariyaratne, P.N., Tennakoon, C., et al. (2012). Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 44, 765–769.10.1038/ng.2295Search in Google Scholar PubMed

Sze, K.M., Chu, G.K., Lee, J.M., and Ng, I.O. (2013). C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 57, 131–139.10.1002/hep.25979Search in Google Scholar PubMed

Tamura, I., Kurimura, O., Koda, T., Ichimura, H., Katayama, S., Kurimura, T., and Inaba, Y. (1993). Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan. J. Gastroenterol. Hepatol. 8, 433–436.10.1111/j.1440-1746.1993.tb01543.xSearch in Google Scholar PubMed

Tariq, Z., Green, C.J., and Hodson, L. (2014). Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)? Liver Int. 34, e180–e190.10.1111/liv.12523Search in Google Scholar PubMed

Thomas, D.L. (2013). Global control of hepatitis C: where challenge meets opportunity. Nat. Med. 19, 850–858.10.1038/nm.3184Search in Google Scholar PubMed PubMed Central

Timpe, J.M., Stamataki, Z., Jennings, A., Hu, K., Farquhar, M.J., Harris, H.J., Schwarz, A., Desombere, I., Roels, G.L., Balfe, P., et al. (2008). Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47, 17–24.10.1002/hep.21959Search in Google Scholar PubMed

Tong, S. and Revill, P. (2016). Overview of hepatitis B viral replication and genetic variability. J. Hepatol. 64, S4–S16.10.1016/j.jhep.2016.01.027Search in Google Scholar PubMed PubMed Central

Toyoda, H., Kumada, T., and Tada, T. (2016). Changes in patient backgrounds may increase the incidence of HCC after SVR in the era of IFN-free therapy for HCV. Hepatology 64, 1818–1819.10.1002/hep.28632Search in Google Scholar PubMed

Tsai, W.C., Hsu, S.D., Hsu, C.S., Lai, T.C., Chen, S.J., Shen, R., Huang, Y., Chen, H.C., Lee, C.H., Tsai, T.F., et al. (2012). MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122, 2884–2897.10.1172/JCI63455Search in Google Scholar PubMed PubMed Central

Tsang, P.S., Trinh, H., Garcia, R.T., Phan, J.T., Ha, N.B., Nguyen, H., Nguyen, K., Keeffe, E.B., and Nguyen, M.H. (2008). Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. Clin. Gastroenterol. Hepatol. 6, 569–574.10.1016/j.cgh.2008.02.037Search in Google Scholar PubMed

Tsuge, M., Hiraga, N., Akiyama, R., Tanaka, S., Matsushita, M., Mitsui, F., Abe, H., Kitamura, S., Hatakeyama, T., Kimura, T., et al. (2010). HBx protein is indispensable for development of viremia in human hepatocyte chimeric mice. J. Gen. Virol. 91, 1854–186410.1099/vir.0.019224-0Search in Google Scholar PubMed

Tu, H., Bonura, C., Giannini, C., Mouly, H., Soussan, P., Kew, M., Paterlini-Brechot, P., Brechot, C., and Kremsdorf, D. (2001). Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res. 61, 7803–7810.Search in Google Scholar

Tu, T., Budzinska, M., Shackel, N., and Urban, S. (2017). HBV DNA integration: molecular mechanisms and clinical implications. Viruses 9, 75.10.3390/v9040075Search in Google Scholar PubMed PubMed Central

Tu, T., Budzinska, M.A., Maczurek, A.E., Cheng, R., Di Bartolomeo, A., Warner, F.J., McCaughan, G.W., McLennan, S.V., and wShackel, N.A. (2014). Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development. Int. J. Mol. Sci. 15, 9422–9458.10.3390/ijms15069422Search in Google Scholar PubMed PubMed Central

Tu, T., Budzinska, M.A., Shackel, N.A., and Jilbert, A.R. (2015a). Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma. Liver Int. 35, 1786–1800.10.1111/liv.12773Search in Google Scholar PubMed

Tu, T., Mason, W.S., Clouston, A.D., Shackel, N.A., McCaughan, G.W., Yeh, M.M., Schiff, E.R., Ruszkiewicz, A.R., Chen, J.W., Harley, H.A., et al. (2015b). Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection. J. Viral Hepat. 22, 737–753.10.1111/jvh.12380Search in Google Scholar PubMed

van der Meer, A.J., Veldt, B.J., Feld, J.J., Wedemeyer, H., Dufour, J.F., Lammert, F., Duarte-Rojo, A., Heathcote, E.J., Manns, M.P., Kuske, L., et al. (2012). Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. J. Am. Med. Assoc. 308, 2584–2593.10.1001/jama.2012.144878Search in Google Scholar PubMed

van Zijl, F., Mair, M., Csiszar, A., Schneller, D., Zulehner, G., Huber, H., Eferl, R., Beug, H., Dolznig, H., and Mikulits, W. (2009). Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 28, 4022–4033.10.1038/onc.2009.253Search in Google Scholar PubMed PubMed Central

Verme, G., Amoroso, P., Lettieri, G., Pierri, P., David, E., Sessa, F., Rizzi, R., Bonino, F., Recchia, S., and Rizzetto, M. (1986). A histological study of hepatitis delta virus liver disease. Hepatology 6, 1303–1307.10.1002/hep.1840060613Search in Google Scholar

Wang, H.C., Huang, W., Lai, M.D., and Su, I.J. (2006). Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 97, 683–688.10.1111/j.1349-7006.2006.00235.xSearch in Google Scholar

Wang, H.C., Wu, H.C., Chen, C.F., Fausto, N., Lei, H.Y., and Su, I.J. (2003). Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am. J. Pathol. 163, 2441–2449.10.1016/S0002-9440(10)63599-7Search in Google Scholar

Wang, H.Y., Chien, M.H., Huang, H.P., Chang, H.C., Wu, C.C., Chen, P.J., Chang, M.H., and Chen, D.S. (2010a). Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases. J. Virol. 84, 3454–3463.10.1128/JVI.02164-09Search in Google Scholar

Wang, Q., Zhang, W., Liu, Q., Zhang, X., Lv, N., Ye, L., and Zhang, X. (2010b). A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. Neoplasia 12, 103–115.10.1593/neo.91298Search in Google Scholar

Wang, L.H., Huang, W., Lai, M.D., and Su, I.J. (2012). Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis. Carcinogenesis 33, 466–472.10.1093/carcin/bgr296Search in Google Scholar

Wei, Y., Fourel, G., Ponzetto, A., Silvestro, M., Tiollais, P., and Buendia, M.A. (1992a). Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors. J. Virol. 66, 5265–5276.10.1128/jvi.66.9.5265-5276.1992Search in Google Scholar

Wei, Y., Ponzetto, A., Tiollais, P., and Buendia, M.A. (1992b). Multiple rearrangements and activated expression of c-myc induced by woodchuck hepatitis virus integration in a primary liver tumour. Res. Virol. 143, 89–96.10.1016/S0923-2516(06)80086-5Search in Google Scholar

Wherry, E.J. (2011). T cell exhaustion. Nat. Immunol. 12, 492–499.10.1038/ni.2035Search in Google Scholar PubMed

Winer, B.Y., Huang, T., Low, B.E., Avery, C., Pais, M.A., Hrebikova, G., Siu, E., Chiriboga, L., Wiles, M.V., and Ploss, A. (2017). Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection. Virology 502, 63–72.10.1016/j.virol.2016.12.017Search in Google Scholar PubMed PubMed Central

Wu, Y., Zhang, T.Y., Fang, L.L., Chen, Z.X., Song, L.W., Cao, J.L., Yang, L., Yuan, Q., and Xia, N.S. (2016). Sleeping Beauty transposon-based system for rapid generation of HBV-replicating stable cell lines. J. Virol. Methods 234, 96–100.10.1016/j.jviromet.2016.04.010Search in Google Scholar PubMed

Xie, H., Song, J., Liu, K., Ji, H., Shen, H., Hu, S., Yang, G., Du, Y., Zou, X., Jin, H., et al. (2008). The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients’ prognosis and hepatitis B virus X protein. Dig. Dis. Sci. 53, 3225–3233.10.1007/s10620-008-0296-9Search in Google Scholar PubMed

Xu, Y., Huang, J., Ma, L., Shan, J., Shen, J., Yang, Z., Liu, L., Luo, Y., Yao, C., and Qian, C. (2016). MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Cancer Lett. 371, 171–181.10.1016/j.canlet.2015.11.034Search in Google Scholar PubMed

Yamane, D., McGivern, D.R., Masaki, T., and Lemon, S.M. (2013). Liver injury and disease pathogenesis in chronic hepatitis C. Curr. Top. Microbiol. Immunol. 369, 263–288.10.1007/978-3-642-27340-7_11Search in Google Scholar PubMed

Yan, H., Zhong, G., Xu, G., He, W., Jing, Z., Gao, Z., Huang, Y., Qi, Y., Peng, B., Wang, H., et al. (2012). Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1, e00049.10.7554/eLife.00049Search in Google Scholar PubMed

Yang, D., Liu, L., Zhu, D., Peng, H., Su, L., Fu, Y.X., and Zhang, L. (2014). A mouse model for HBV immunotolerance and immunotherapy. Cell Mol. Immunol. 11, 71–78.10.1038/cmi.2013.43Search in Google Scholar PubMed PubMed Central

Yang, H.I., Sherman, M., Su, J., Chen, P.J., Liaw, Y.F., Iloeje, U.H., and Chen, C.J. (2010). Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J. Clin. Oncol. 28, 2437–2444.10.1200/JCO.2009.27.4456Search in Google Scholar PubMed

Yang, H.I., Yeh, S.H., Chen, P.J., Iloeje, U.H., Jen, C.L., Su, J., Wang, L.Y., Lu, S.N., You, S.L., Chen, D.S., et al. (2008a). Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J. Natl. Cancer Inst. 100, 1134–1143.10.1093/jnci/djn243Search in Google Scholar PubMed PubMed Central

Yang, H.I., Yeh, S.H., Chen, P.J., Iloeje, U.H., Jen, C.L., Su, J., Wang, L.Y., Lu, S.N., You, S.L., Chen, D.S., et al. (2008b). Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J. Natl. Cancer Inst. 100, 1134–1143.10.1093/jnci/djn243Search in Google Scholar

Yang, W. and Summers, J. (1998). Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion. J. Virol. 72, 8710–8717.10.1128/JVI.72.11.8710-8717.1998Search in Google Scholar PubMed PubMed Central

Yasui, M., Kanemaru, Y., Kamoshita, N., Suzuki, T., Arakawa, T., and Honma, M. (2014). Tracing the fates of site-specifically introduced DNA adducts in the human genome. DNA Repair (Amst.) 15, 11–20.10.1016/j.dnarep.2014.01.003Search in Google Scholar PubMed

Zeigerer, A., Wuttke, A., Marsico, G., Seifert, S., Kalaidzidis, Y., and Zerial, M. (2017). Functional properties of hepatocytes in vitro are correlated with cell polarity maintenance. Exp. Cell Res. 350, 242–252.10.1016/j.yexcr.2016.11.027Search in Google Scholar PubMed

Zeisel, M.B., Felmlee, D.J., and Baumert, T.F. (2013). Hepatitis C virus entry. Curr. Top. Microbiol. Immunol 369, 87–112.10.1007/978-3-642-27340-7_4Search in Google Scholar PubMed

Zhang, X., Dong, N., Zhang, H., You, J., Wang, H., and Ye, L. (2005). Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J. Lab. Clin. Med. 145, 98–104.10.1016/j.lab.2004.11.018Search in Google Scholar PubMed

Zona, L., Lupberger, J., Sidahmed-Adrar, N., Thumann, C., Harris, H.J., Barnes, A., Florentin, J., Tawar, R.G., Xiao, F., Turek, M., et al. (2013). HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. Cell Host. Microbe. 13, 302–313.10.1016/j.chom.2013.02.006Search in Google Scholar PubMed

Zoulim, F. and Durantel, D. (2015). Antiviral therapies and prospects for a cure of chronic hepatitis B. Cold Spring Harb. Perspect. Med. 5, a021501.10.1101/cshperspect.a021501Search in Google Scholar PubMed PubMed Central

Zucman-Rossi, J., Villanueva, A., Nault, J.C., and Llovet, J.M. (2015). Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology 149, 1226–1239 e1224.10.1053/j.gastro.2015.05.061Search in Google Scholar PubMed